BEAT (HeartBeam) 3-Year Revenue Growth Rate : 0.00% (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is HeartBeam 3-Year Revenue Growth Rate?

HeartBeam's Revenue per Share for the three months ended in Sep. 2024 was $0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Competitive Comparison of HeartBeam's 3-Year Revenue Growth Rate

For the Health Information Services subindustry, HeartBeam's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HeartBeam's 3-Year Revenue Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, HeartBeam's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where HeartBeam's 3-Year Revenue Growth Rate falls into.

HeartBeam 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

HeartBeam (NAS:BEAT) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

HeartBeam 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of HeartBeam's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

HeartBeam Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » HeartBeam Inc (NAS:BEAT) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

2118 Walsh Avenue, Suite 210, Santa Clara, CA, USA, 95050

Website

https://www.heartbeam.com

HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.

Executives

Urioste George De	director	2118 WALSH AVENUE, SUITE 210, SANTA CLARA CA 95050
Kenneth Harry Persen	officer: Chief Technology Officer	2118 WALSH AVENUE, SUITE 210, SANTA CLARA CA 95050
Robert Paul Eno	officer: President	2118 WALSH AVE, SUITE 210, SANTA CLARA CA 95050
Michael R Jaff	director	2118 WALSH AVENUE, SUITE 210, SANTA CLARA CA 95050
Mark E Strome	10 percent owner	100 WILSHIRE BLVD, 15TH FL, SANTA MONICA CA 90401
Nelson Kenneth Warwick Iii	director	2118 WALSH AVENUE, SUITE 210, SANTA CLARA CA 95050
Richard D Brounstein	officer: Chief Financial Officer	2118 WALSH AVENUE, SUITE 210, SANTA CLARA CA 95050
Alan Baumel	officer: Chief Operating Officer	2118 WALSH AVE, SUITE 210, SANTA CLARA CA 94050
Marga Ortigas-wedekind	director	2118 WALSH AVENUE, SUITE 210, SANTA CLARA CA 95050
Richard M Ferrari	director, officer: Exec Chm of the BOD	2118 WALSH AVENUE, SUITE 210, SANTA CLARA CA 95050
Branislav Vajdic	10 percent owner, officer: Chief Executive Officer	2118 WALSH AVENUE, SUITE 210, SANTA CLARA CA 95050
Willhem Elfrink	director	2118 WALSH AVE, SUITE 210, SANTA CLARA CA 95050
Jon Patrick Hunt	officer: Chief Business Officer	2118 WALSH AVE, SUITE 210, SANTA CLARA CA 95050